Numbers of stroke events, incidence rates (IRs) per 100 person-years and incidence rate ratios (IRRs) for semaglutide compared with DPP4i are reported
We believe that if you are going to put something in your body, it should be the best version of that ingredient possible
Location: Indianapolis, IndianaWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Zepbound (tirzepatide) and Mounjaro (tirzepatide)FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Eli Lilly promoted Mounjaro and Zepbound in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner, despite FDAs prior correspondence (advisory comments dated June 13, 2022 and June 21, 2022)
Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways
Further information on GORD management in adults is available via NICE Clinical Knowledge Summaries (CKS)
(2013), Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis , Nature Med
